GCN
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Jan 2019)
What this means for you
This application is over — abandoned 07 Jan 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87307659
- Mark type
- Stylized text
- Filed
- 19 Jan 2017
- Published for opposition
- 13 Jun 2017
- Abandoned
- 07 Jan 2019
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of obesity and inducing weight loss
- Class 044 — Medical, beauty and agricultural services: Online pharmaceutical advice, namely, providing online consultation and information for the ordering of pharmaceuticals; Providing information in the field of weight management and the treatment of obesity
Owner
- NALPROPION PHARMACEUTICALS, INC., MORRISTOWN, NJ, US
- Orexigen Therapeutics, Inc., La Jolla, CA, US
- Orexigen Therapeutics, Inc., La Jolla, CA, US
Prosecution history
- 07 Jan 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Jan 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Aug 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 06 Aug 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Aug 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Jun 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jun 2018 — SOU EXTENSION 1 GRANTED
- 04 Jun 2018 — SOU EXTENSION 1 FILED
- 04 Jun 2018 — SOU TEAS EXTENSION RECEIVED
- 05 Dec 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Oct 2017 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 12 Jul 2017 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 13 Jun 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jun 2017 — PUBLISHED FOR OPPOSITION
- 24 May 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED